SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-050755
Filing Date
2020-11-05
Accepted
2020-11-04 21:31:52
Documents
77
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q stro-10q_20200930.htm   iXBRL 10-Q 3669534
2 EX-10.1 stro-ex101_57.htm EX-10.1 1149545
3 EX-31.1 stro-ex311_6.htm EX-31.1 17667
4 EX-31.2 stro-ex312_7.htm EX-31.2 16899
5 EX-32.1 stro-ex321_9.htm EX-32.1 6614
6 EX-32.2 stro-ex322_8.htm EX-32.2 6644
7 GRAPHIC gl5pcr2yykp4000003.jpg GRAPHIC 53216
8 GRAPHIC gl5pcr2yykp4000001.jpg GRAPHIC 40093
9 GRAPHIC gl5pcr2yykp4000002.jpg GRAPHIC 55098
  Complete submission text file 0001564590-20-050755.txt   13431046

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA stro-20200930.xsd EX-101.SCH 81479
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stro-20200930_cal.xml EX-101.CAL 43674
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stro-20200930_def.xml EX-101.DEF 310713
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE stro-20200930_lab.xml EX-101.LAB 588028
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stro-20200930_pre.xml EX-101.PRE 458399
15 EXTRACTED XBRL INSTANCE DOCUMENT stro-10q_20200930_htm.xml XML 2186106
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38662 | Film No.: 201288394
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences